vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and IHS Holding Ltd (IHS). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $254.0M, roughly 1.9× IHS Holding Ltd). On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 0.1%). IHS Holding Ltd produced more free cash flow last quarter ($178.6M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -22.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

IHS Towers is one of the largest independent owners, operators and developers of shared communications infrastructure in the world, with operations across Africa and Latin America. It is the fifth-largest independent multinational tower company in the world.

CLOV vs IHS — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.9× larger
CLOV
$487.7M
$254.0M
IHS
Growing faster (revenue YoY)
CLOV
CLOV
+44.7% gap
CLOV
44.7%
0.1%
IHS
More free cash flow
IHS
IHS
$247.6M more FCF
IHS
$178.6M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-22.0%
IHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
IHS
IHS
Revenue
$487.7M
$254.0M
Net Profit
$-49.3M
Gross Margin
83.6%
Operating Margin
-10.1%
Net Margin
-10.1%
Revenue YoY
44.7%
0.1%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
IHS
IHS
Q4 25
$487.7M
$254.0M
Q3 25
$496.6M
$455.1M
Q2 25
$477.6M
$433.3M
Q1 25
$462.3M
$439.6M
Q4 24
$337.0M
$253.8M
Q3 24
$331.0M
$420.3M
Q2 24
$356.3M
$435.4M
Q1 24
$346.9M
$417.7M
Net Profit
CLOV
CLOV
IHS
IHS
Q4 25
$-49.3M
Q3 25
$-24.4M
$147.4M
Q2 25
$-10.6M
$32.3M
Q1 25
$-1.3M
$30.7M
Q4 24
$-22.1M
Q3 24
$-9.2M
$-205.7M
Q2 24
$7.4M
$-124.3M
Q1 24
$-19.2M
$-1.6B
Gross Margin
CLOV
CLOV
IHS
IHS
Q4 25
83.6%
Q3 25
47.5%
Q2 25
51.3%
Q1 25
51.4%
Q4 24
72.1%
Q3 24
24.5%
52.0%
Q2 24
30.3%
52.5%
Q1 24
23.6%
39.1%
Operating Margin
CLOV
CLOV
IHS
IHS
Q4 25
-10.1%
Q3 25
-4.9%
35.1%
Q2 25
-2.2%
33.8%
Q1 25
-0.3%
37.1%
Q4 24
-6.4%
Q3 24
-2.7%
29.9%
Q2 24
2.0%
34.0%
Q1 24
-6.5%
-1.7%
Net Margin
CLOV
CLOV
IHS
IHS
Q4 25
-10.1%
Q3 25
-4.9%
32.4%
Q2 25
-2.2%
7.5%
Q1 25
-0.3%
7.0%
Q4 24
-6.6%
Q3 24
-2.8%
-48.9%
Q2 24
2.1%
-28.5%
Q1 24
-5.5%
-372.8%
EPS (diluted)
CLOV
CLOV
IHS
IHS
Q4 25
Q3 25
$0.44
Q2 25
$0.10
Q1 25
$0.10
Q4 24
Q3 24
$-0.61
Q2 24
$-0.36
Q1 24
$-4.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
IHS
IHS
Cash + ST InvestmentsLiquidity on hand
$78.3M
$825.7M
Total DebtLower is stronger
$3.1B
Stockholders' EquityBook value
$308.7M
$-89.8M
Total Assets
$541.0M
$4.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
IHS
IHS
Q4 25
$78.3M
$825.7M
Q3 25
$647.6M
Q2 25
$531.8M
Q1 25
$629.0M
Q4 24
$194.5M
$578.0M
Q3 24
$288.0M
$397.5M
Q2 24
$254.8M
$445.7M
Q1 24
$208.3M
$333.2M
Total Debt
CLOV
CLOV
IHS
IHS
Q4 25
$3.1B
Q3 25
$3.3B
Q2 25
$3.2B
Q1 25
$3.4B
Q4 24
$3.3B
Q3 24
$3.5B
Q2 24
$3.6B
Q1 24
$3.5B
Stockholders' Equity
CLOV
CLOV
IHS
IHS
Q4 25
$308.7M
$-89.8M
Q3 25
$340.9M
$38.1M
Q2 25
$344.2M
$-98.4M
Q1 25
$336.1M
$-184.4M
Q4 24
$341.1M
$-314.4M
Q3 24
$342.2M
$-284.7M
Q2 24
$324.9M
$-308.3M
Q1 24
$292.5M
$-163.2M
Total Assets
CLOV
CLOV
IHS
IHS
Q4 25
$541.0M
$4.5B
Q3 25
$559.7M
$4.7B
Q2 25
$575.0M
$4.5B
Q1 25
$583.7M
$4.4B
Q4 24
$580.7M
$4.2B
Q3 24
$653.0M
$4.6B
Q2 24
$674.2M
$4.5B
Q1 24
$671.8M
$4.6B
Debt / Equity
CLOV
CLOV
IHS
IHS
Q4 25
Q3 25
85.85×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
IHS
IHS
Operating Cash FlowLast quarter
$-66.9M
$246.9M
Free Cash FlowOCF − Capex
$-69.0M
$178.6M
FCF MarginFCF / Revenue
-14.1%
70.3%
Capex IntensityCapex / Revenue
0.4%
26.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$718.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
IHS
IHS
Q4 25
$-66.9M
$246.9M
Q3 25
$12.1M
$251.3M
Q2 25
$5.4M
$237.7M
Q1 25
$-16.3M
$200.3M
Q4 24
$34.8M
$344.4M
Q3 24
$50.0M
$174.5M
Q2 24
$44.8M
$134.7M
Q1 24
$25.9M
$75.8M
Free Cash Flow
CLOV
CLOV
IHS
IHS
Q4 25
$-69.0M
$178.6M
Q3 25
$11.4M
$189.2M
Q2 25
$4.8M
$197.7M
Q1 25
$-16.5M
$153.2M
Q4 24
$33.3M
$282.9M
Q3 24
$49.6M
$122.3M
Q2 24
$44.4M
$74.2M
Q1 24
$25.5M
$14.8M
FCF Margin
CLOV
CLOV
IHS
IHS
Q4 25
-14.1%
70.3%
Q3 25
2.3%
41.6%
Q2 25
1.0%
45.6%
Q1 25
-3.6%
34.8%
Q4 24
9.9%
111.5%
Q3 24
15.0%
29.1%
Q2 24
12.5%
17.0%
Q1 24
7.3%
3.5%
Capex Intensity
CLOV
CLOV
IHS
IHS
Q4 25
0.4%
26.9%
Q3 25
0.1%
13.6%
Q2 25
0.1%
9.2%
Q1 25
0.0%
10.7%
Q4 24
0.5%
24.2%
Q3 24
0.1%
12.4%
Q2 24
0.1%
13.9%
Q1 24
0.1%
14.6%
Cash Conversion
CLOV
CLOV
IHS
IHS
Q4 25
Q3 25
1.70×
Q2 25
7.36×
Q1 25
6.52×
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons